These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12589747)

  • 1. Solution structure of the chick TGFbeta type II receptor ligand-binding domain.
    Marlow MS; Brown CB; Barnett JV; Krezel AM
    J Mol Biol; 2003 Feb; 326(4):989-97. PubMed ID: 12589747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure and backbone dynamics of the TGFbeta type II receptor extracellular domain.
    Deep S; Walker KP; Shu Z; Hinck AP
    Biochemistry; 2003 Sep; 42(34):10126-39. PubMed ID: 12939140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H, 13C, and 15N backbone assignments of the ligand binding domain of TGFbeta type II receptor.
    Marlow MS; Chim N; Brown CB; Barnett JV; Krezel AM
    J Biomol NMR; 2000 Aug; 17(4):349-50. PubMed ID: 11014599
    [No Abstract]   [Full Text] [Related]  

  • 4. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis.
    Anders RA; Doré JJ; Arline SL; Garamszegi N; Leof EB
    J Biol Chem; 1998 Sep; 273(36):23118-25. PubMed ID: 9722540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of the type II TGF-beta receptor indicates a ligand-binding site distinct from that of the type II activin receptor.
    Guimond A; Sulea T; Pen A; Ear P; O'Connor-McCourt MD
    FEBS Lett; 2002 Mar; 515(1-3):13-9. PubMed ID: 11943186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
    Hart PJ; Deep S; Taylor AB; Shu Z; Hinck CS; Hinck AP
    Nat Struct Biol; 2002 Mar; 9(3):203-8. PubMed ID: 11850637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding.
    De Crescenzo G; Pham PL; Durocher Y; O'Connor-McCourt MD
    J Mol Biol; 2003 May; 328(5):1173-83. PubMed ID: 12729750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants of binding and specificity in transforming growth factor-receptor interactions.
    Shah PK; Buslje CM; Sowdhamini R
    Proteins; 2001 Dec; 45(4):408-20. PubMed ID: 11746688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.
    Taniguchi A; Matsuzaki K; Nakano K; Kan M; McKeehan WL
    In Vitro Cell Dev Biol Anim; 1998 Mar; 34(3):232-8. PubMed ID: 9557941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.
    Greenwald J; Fischer WH; Vale WW; Choe S
    Nat Struct Biol; 1999 Jan; 6(1):18-22. PubMed ID: 9886286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential resonance assignments of the extracellular ligand binding domain of the human TGF-beta type II receptor.
    Hinck AP; Walker KP; Martin NR; Deep S; Hinck CS; Freedberg DI
    J Biomol NMR; 2000 Dec; 18(4):369-70. PubMed ID: 11200535
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential resonance assignments of the extracellular domain of the human TGFbeta type II receptor in complex with monomeric TGFbeta3.
    Ilangovan U; Deep S; Hinck CS; Hinck AP
    J Biomol NMR; 2004 May; 29(1):103-4. PubMed ID: 15017149
    [No Abstract]   [Full Text] [Related]  

  • 14. The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain.
    Boesen CC; Radaev S; Motyka SA; Patamawenu A; Sun PD
    Structure; 2002 Jul; 10(7):913-9. PubMed ID: 12121646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of Smad2 recognition by the Smad anchor for receptor activation.
    Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y
    Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFbeta receptor independent manner.
    Parker WL; Goldring MB; Philip A
    J Bone Miner Res; 2003 Feb; 18(2):289-302. PubMed ID: 12568406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a transforming growth factor-beta Type II receptor cDNA from Xenopus laevis.
    Dhanasekaran SM; Vempati UD; Kondaiah P
    Gene; 2001 Jan; 263(1-2):171-8. PubMed ID: 11223255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human transforming growth factor-beta type II receptor that contains an insertion in the extracellular domain.
    Hirai R; Fijita T
    Exp Cell Res; 1996 Feb; 223(1):135-41. PubMed ID: 8635485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor.
    De Crescenzo G; Hinck CS; Shu Z; Zúñiga J; Yang J; Tang Y; Baardsnes J; Mendoza V; Sun L; López-Casillas F; O'Connor-McCourt M; Hinck AP
    J Mol Biol; 2006 Jan; 355(1):47-62. PubMed ID: 16300789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.
    Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS
    Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.